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Abstract
Protein P7 is a component of the cystovirus viral polymerase complex. In the unpackaged
procapsid, the protein is situated in close proximity to the viral directed RNA polymerase,
P2. Cryo-electron microscopy difference maps from the species ϕ6 procapsid have demon-
strated that P7 and P2 likely interact prior to viral RNA packaging. The location of P7 in the
post-packaged nucleocapsid (NC) remains unknown. P7 may translocate closer to the five-
fold axis of a filled procapsid but this has not been directly visualized. We propose that
monoclonal antibodies (Mabs) can be selected that serve as probe- reagents for viral as-
sembly and structure. A set of Mabs have been isolated that recognize and bind to the ϕ6
P7. The antibody set contains five unique Mabs, four of which recognize a linear epitope
and one which recognizes a conformational epitope. The four unique Mabs that recognize a
linear epitope display restricted utilization of Vκ and VH genes. The restricted genetic range
among 4 of the 5 antibodies implies that the antibody repertoire is limited. The limitation
could be the consequence of a paucity of exposed antigenic sites on the ϕ6 P7 surface. It is
further demonstrated that within ϕ6 nucleocapsids that are primed for early-phase transcrip-
tion, P7 is partially accessible to the Mabs, indicating that the nucleocapsid shell (protein
P8) has undergone partial disassembly exposing the protein’s antigenic sites.
Introduction
The cystoviridae family of viruses, of which ϕ6 was the first discovered species, contain three
segments of double stranded RNA. Bacteriophage ϕ6 and its relatives are model systems for
virus assembly, genome packaging and dsRNA polymerization. The RNA packaging, replica-
tion, transcription mechanism, and overall structure resembles that of reoviruses making the
species an excellent model system to study these important pathogens. The initial step in cysto-
viridae replication is the assembly of a closed and unexpanded, dodecahedral-shaped procapsid
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(PC). The RNA packaging proceeds in a specific order with the small (2948 bp) viral RNA seg-
ment packaged first, followed by the middle (4063 bp) and large (6374 bp) segments [1–3].
Step-wise expansion of the PC accompanies the RNA packaging [4]. Ultimately all three ds-
RNA segments are enclosed into a nucleocapsid (NC) surrounded by a lipoprotein envelope to
constitute the mature viral particle. The outer layer of the NC is a shell composed of a matrix
assembled of protein P8 [5–7] that upon cell penetration facilitates an endocytic plasma mem-
brane penetration and is thought to disassemble during viral entry [8]. The P8 shell is com-
posed of 200 trimers arranged as a T = 13 lattice that partially covers the filled PC [5,9,10].
During genome packaging the PC undergoes significant conformational morphogenesis
with the sequential expansion revealing unique binding sites for each of the three viral RNA
segments [11,12]. The PC is composed of four proteins, P1, P2, P4, and P7, which are responsi-
ble for RNA packaging, transcription, and genome replication [11,13]. Three of the four pro-
teins (P1, P2 and P4) are known to have specific functions in regard to the packaging and
replication of viral RNA. The entire PC framework is composed of P1 which has RNA binding
activity. The atomic structure of P1 for both ϕ6 and ϕ8 has recently been determined and
shown to be a flattened trapezoid in shape that adapts to two conformations, P1A and P1B,
that undergo conformational changes when maturing from the unexpanded PC to the RNA
packaged NC [14–16]. A hexamer of the nucleotide triphosphorylase, P4, forms the packaging
portal responsible for RNA transport into the expanding PC. The viral RNA-directed RNA po-
lymerase (RdRP), P2, is required for the replication of the single stranded RNA to the double-
stranded RNA (dsRNA) genome [5].
P7 is the least characterized of the PC proteins and its precise function still remains undeter-
mined. It is required for efficient PC assembly and transcription [17], and RNA packaging
[18,19]. In ϕ6, P7 has a molecular mass of 17168 Da. The ϕ6 virion can potentially contain 60
copies of P7 (three copies at each of the 20 three-fold symmetry axes); but there is a controver-
sy regarding occupancy in recombinant PC particles: SunBamford and Poranen [20] noted
that the same amount of P7 is in recombinant PC particles as in the complete virion. Our previ-
ous publication described approximately 20 copies of P7 protein per PC particle [21]; while
NemecekQiaoMindichSteven and Heymann [16] observed even less occupancy for P7, at only
12 copies in a complete PC. The occupancy of P7 in mature viruses has not been determined
and may differ from recombinant PC particles. There is evidence that P7 forms an elongated
dimer in solution [17], but in both the PC and NC, P7 is seen to exist as a monomer. Poranen-
ButcherSimonovLaurinmaki and Bamford [22] observed that an excess concentration of P7 ac-
celerated assembly of P1 in vitro, indicating that P7 may stabilize P1. Study of self-assembly of
PC particles shows potential competition between P2 and P7 proteins [16]. In the presence of
an excess of P7, the number of P2 copies decreases from 12 to 6 copies, whereas the number of
P7 copies increases from 36 to 60 copies per particle [20]. In prior work, we proposed that P7 is
located “inside” the unexpanded PC core near the three-fold axes and that P7 stabilizes P2 in
position close to the three-fold axis [21].
The structure of P7 from the related cystovirus ϕ12 has been determined by X-ray crystal-
lography [23]. Most interestingly, the protein is seen to be composed of two distinct domains
in which the N-terminal core region (1–129) of P7 forms a homodimeric α/β-fold, having
structural similarities with breast cancer gene 1 (BRCA1) C-terminal domains implicated in
multiple protein–protein interactions in DNA repair proteins. The C-terminal tail consisting
of approximately 30 to 40 amino acids is less ordered structurally and nuclear magnetic reso-
nance analysis strongly suggests that it is capable of interacting with the viral RNA and the
RdRP. Recently, difference maps generated from single particle reconstructions show that in
ϕ6, P7 is located very near the inner three-fold axis of symmetry in the unpackaged and
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unexpanded PC [21]. In that work, it was noted that P7 interacts with P2, and it is proposed
that the protein stabilizes the location of P2 near the inner three-fold axis.
Juuti and Bamford [17] noted that P7 is accessible to polyclonal antibodies from the NC sur-
face and that protein P8 is released by the polyclonal antibodies. While the NC structure is
well-established [5,10], actively transcribing NCs have not been directly observed and the pre-
cise position and translocation of the RNA portal protein elements have not been determined.
In this paper, we report the isolation of a set of monoclonal antibodies (Mabs) with specificity
to unique epitopes of P7. These Mabs are utilized as reagents for a first determination of P7 ac-
cessibility in a transcribing NC structure. We note that under conditions that favor early-phase
ϕ6 transcription, P7 is accessible to antibodies in situ. The Mabs show potential as reagents to
reveal viral structure during assembly and disassembly.
Materials and Methods
Cloning, expression, and purification of P7
The ϕ6 P7 coding region was polymerase chain reaction (PCR) amplified from a pLM687 plas-
mid template [24] using oligonucleotides OL161 5’-TACTGACAATCCTGTCGTTA-3’ and
OL162 5’-TCATCGACATCGAACGGTTG-3’ as upstream and downstream primers, respec-
tively. The PCR product was initially inserted into PCR2.1 TOPO and the recombinant plas-
mid, designated pPG126, was double digested with restriction endonucleases Ndel and EcoRI.
A 498 bp fragment was isolated and ligated with pET28-a vector (Novagen, Madison, WI) at
the Ndel and EcoRI sites. The ligation product was transformed in E. coli XL-1 blue supercom-
petent cells (Novagen, Madison, WI) and selected for kanamycin resistance (50 μg/ml). The
positive clone selected was designated pPG128 and was subsequently transformed into T7 Ex-
press lysY/Iq Competent E. coli (New England Biolabs, Ipswich, MA). Five ml of overnight cul-
ture of the transformants were inoculated in 250 ml Luria-Bertani liquid media, supplemented
with 50 μg/ml of kanamycin, and grown at 27°C for 14 h. P7 protein expression was then in-
duced by adding 1 mM of isopropyl-thio-galactoside (IPTG) and the cells were grown at 27°C
for an additional 4 h. The expressed protein was visualized by using 12% SDS-PAGE gel of the
cell’s samples before and after induction. Induced cells were pelleted by centrifugation at 7000g
for 30 min at 4°C and the pellets were stored at −80°C.
The frozen pellets were thawed on ice and re-suspended in 5 ml of lysis buffer consisting of
50 mM of NaH2PO4, 500 mM of NaCl, 1 mM of MgCl2, 10 mM of imidazole and protease in-
hibitor cocktail (Roche, Nutley, NJ). The cells were sonicated and lysed on ice by using a
Microtip Misonix S-4000 sonicator (Qsonica LLC Newtown, CT), at 50% power (13 W) for
10 min, with a repeating power cycle of 10 s ON, 10 s OFF. In order to remove cells debris, the
sonicated samples were centrifuged at 20000g for 30 min. The supernatant containing soluble
P7 was mixed with Ni-NTA His-Bind resin (Novagen, Madison, WI) pre-equilibrated with
washing buffer (50 mM of NaH2PO4, 540 mM of NaCl, 1 mM of MgCl2, 1% glycerol, 20 mM
of Imidazole, pH 8.0) and incubated for 2 h in a shaker at room temperature. A gravity flow
column was packed with beads incubated with the cell’s supernatant and washed with 50 ml of
washing buffer. P7 was eluted with 3 ml of elution buffer (50 mM of NaH2PO4, 540 mM of
NaCl, 1 mM of MgCl2, 1% glycerol, 250 mM of imidazol, pH 8.0) and the sample was desalted
and concentrated by using Amicron (Millipore, Billerica, MA) 10 kDa cutoff filter.
The P7 concentration was estimated from the density of the band on a Coomassie-stained
SDS-PAGE gel. The density data were compared with known amounts of lysozyme protein
(MW 14.3 kDa) loaded on the same gel. The amount of protein was estimated by integrating
the area under the band curve and applying a background correction.
P7 Probed by Monoclonal Antibodies
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NC purification
The growth and purification of ϕ6 followed the procedure described by Mindich et al. [25].
The viral envelope was removed with 1% Triton X-100 to yield isolated NCs by the procedure
similar to the one outlined by de HaasPaateroMindichBamford and Fuller [26]. Analysis of vi-
rion size (NC diameter is ~58 nm; complete virion diameter is ~86 nm) in TEMmicrographs
indicated that this procedure resulted in near total removal of the viral envelope.
Antibody production
Four BALB/c female mice were each immunized with 50 μg of P7 in complete Freund’s adju-
vant (CFA) on day 0. The mice were boosted on days 21 and 51 with 25 μg and 50 μg of native
P7 in incomplete Freund’s adjuvant (IFA) respectively. The mice were bled immediately before
each immunization and the sera samples were tested for anti-P7 antibodies by ELISA. One
week after the first immunization, the mice were bled and the sera samples were tested for the
presence of anti-P7 IgM antibody. The mice were then bled four days after the 1st boost and
tested for the presence of anti-P7 IgG antibody. The second boost was performed four days be-
fore fusion. Spleen cells from immunized mice were fused with NSO myeloma cell (Sigma Al-
drich, St. Louis, MO) using polyethylene glycol 4000 and the hybridoma cells were grown in
hypoxanthine aminopteran thymidine (HAT) selection medium.
Hybridomas secreting antibodies that were positive by ELISA for P7 antigen were subcloned
by limiting dilution in complete HAT-DME (Dulbecco’s Modified Eagles) medium supple-
mented with 10% fetal bovine serum, 1% glutamine, 10% NCTC-109 (Life Technologies,
Grand Island, NY), 1% of MEM nonessential amino acids (Corning cellgro, Manassas, VA),
and 1% penicillin-streptomycin. Hybridoma Cloning Factor (Thermo Fisher Scientific, Wal-
tham, MA) was used to support cell growth. Only subclones, whose secreted antibodies bound
P7 but were non-reactive to BSA and a 6-histidine tagged EBNA-1 protein were selected for fu-
ture propagation. The His-tag EBNA protein was used as a negative control for 6x-his antigen.
Initially five selected subcloned hybridomas were grown in Serum-Free DME medium (Sigma-
Aldrich, St Louis, MO) to obtain a total of 500 ml of supernatants. All the supernatants were
tested by ELISA for anti-P7 IgG antibody and the Mabs labeled as 6C3, 2D11, 1F11, 1B6 and
1C10. A germline analysis search demonstrates that 2D11 is similar to 1B6; 1C10 is similar to
1F11; and therefore, could be derived from the same myeloma fusion (Table 1). In Table 1, the
germline gene with the highest alignment is recorded.
Anti-P7 IgG Mabs were purified from the supernatants by using Gamma Bind Plus Sephar-
ose (GE Healthcare Life Sciences, Pittsburgh, PA). The antibody was eluted with 8 ml of 0.1 M
glycine at pH 3.0 and immediately adjusted to neutral pH with 800 μl of 1 M Tris-HCl at pH
8.0. The antibody was de-salted and concentrated by an Amicron 10 kDa cut-off filter. Anti-
body concentration was determined from optical density with a NanoDrop spectrophotometer
(NanoDrop division of ThermoScientific, Wilmington, DE).
Table 1. Germline Assignments (IgBLAST).
Mab VH JH # mutations Vκ Jκ # mutations
1B6 V5-9-3*01 2 18 V4-59*01 5 9
2D11 V5-9-3*01 2 20 V4-59*01 5 10
1C10 V5-17*02 4 5 V4-59*01 5 5
1F11 V5-17*02 4 5 V4-59*01 5 9
6C3 V2-9-1*01 3 7 V8-21*01 4 11
doi:10.1371/journal.pone.0122160.t001
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Animal Welfare
The IACUC of The City College of New York/CUNYMedical School approved this study—
Approval Number 832.2. Mice were anesthetized with isofluorane prior to blood drawing and
the mice are euthanized by deep isofluorane inhalation followed by cervical dislocation or
CO2 asphyxiation.
Isotype ELISAs
The Mabs were isotyped by using an indirect ELISA method. Serial dilutions of the Mabs, start-
ing from an initial concentration of 500 ng/ml were added to wells, and plates were incubated
for 1 h at 37°C. The isotype specificity of the Mabs was detected by incubating coated plates
with the following goat anti-mouse antibodies conjugated to alkaline phosphatase: anti-IgG1,
anti-IgG2a, anti-IgG2b, anti-IgG3 anti-kappa and anti-lambda for 1 h at 37°C. Phosphatase
Substrate (Sigma-Aldrich) was added and color development was measured using a Titertek
ELISA reader at 405 nm.
cDNA synthesis
Total RNA from 100% confluent T25 flasks were extracted for all four hybridoma cultures by
using the TRIzol method, iso-propanol concentrated, and air-dried. The RNA was resuspended
in 50 μl of Diethylpyrocarbonate (DEPC) water. The first strand of cDNA was synthesized
from the RNA template by using the SuperScript III System for RT-PCR (Invitrogen, Thermo
Fisher Scientific, Waltham, MA). Briefly, the 2 μl of total RNA isolated from T25 flasks was re-
verse transcribed in a reaction volume of 20 μl containing 1 mM of oligo(dT)20, 10 nmol of
each of four dNTPs, 40 U of RNaseOUT, 1x RT buffer, 100 nmol of MgCl2, 100 U of Super-
Script III reverse transcriptase and 0.2 nmol of dithiothreitol (DTT). Reverse transcription re-
actions were performed at 50°C for 50 min followed by 85°C for 5 min. Then 1 μl of RNase H
was added and samples were incubated at 37°C for 20 min.
Immunoglobulin VH and Vκ transcripts were amplified independently by PCR (High-Fidel-
ity Phusion PCR kit by Finnzymes, Fisher Scientific, Pittsburgh, PA) using 2 μl of RT reaction
product as a template. Universal VH forward and reverse γ1 primers and universal forward Vκ
and reverse κ primers. were designed by TillerBusse and Wardemann [27]. All PCRs were per-
formed in 50 μl total reaction volume at 94°C for 15 s followed by 50 cycles at 94°C for 30 s;
60°C (VH) or 50°C (Vκ) for 30 s; 72°C for 45 s (VH) or 55 s (Vκ); and a final extension at 72°C
for 10 min. Amplified PCR products were gel purified by using QIAquick Gel Extraction Kit
(Qiagen, Valencia, CA). Purified products were sequenced (Macrogen Service, Rockville, MD).
Western Blot
For the western blot analysis, 0.3 μg of purified P7 was loaded on to a 12% SDS-PAGE gel.
Identical loadings were performed for each of the five Mabs. After gel separation, the proteins
were transferred onto a nitrocellulose transfer membrane (BA-S 85 by OPTITRAN) and
stained with 0.1% Ponceau S (Sigma-Aldrich, St. Louis, MO) in 5% glacial acetic acid to visual-
ize the transferred bands. The membranes were then cut into five sections for each of the
Mabs. The membranes were blocked in 5% skim milk and 0.01% Tween20 in PBS, and then in-
cubated overnight in the presence of 1 μg/ml of each Mab in PBS and 0.01% Tween20. The
membranes were then incubated in the presence of a 1:20000 dilution of goat anti-mouse IgG
conjugated with HRP (horse radish peroxidase) added to 3% skim milk and 0.01% Tween20 in
PBS. To develop the Western Blot Marker (Magic Mark XPWestern Standard by Invitrogen)
the 1 μl of Precision Protein StrepTactin-HRP conjugated (Bio-Rad Life Sciences, Hercules,
P7 Probed by Monoclonal Antibodies
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CA) was added to each of 10 ml of secondary antibody solution. The membranes were incubat-
ed in Pierce ECLWestern Blotting Substrate (Thermo Fisher Scientific, Rockford, IL) and then
Kodak X-OMAT LS film was exposed to visualize the HRP luminescence.
ELISAs to determine whether two Mabs compete for the same or
different epitopes on P7
To determine whether two Mabs bound to the same or different epitopes on P7, a mixture of
two anti-P7 Mabs were applied to P7 coated ELISA plates. The ELISA plates were coated with
25 ng/ml (1.25 ng per well of native P7). The optimal concentration of P7 antigen per well was
obtained by titrating P7 to determine the linear range of activity. One of the Mabs was kept at a
constant concentration of 1000 ng/ml (saturation concentration) while the concentration of
the other competing Mab was varied in the range of 3 ng/ml to 1000 ng/ml. As a control, a
non-competing ELISA was performed for each of the five Mabs in a range of concentrations
from 3 ng/ml to 1000 ng/ml. Secondary anti-mouse IgG antibodies conjugated to alkaline
phosphatase were added followed by substrate solution.
6C3 Mab biotinylation
The 6C3 Mab was biotinylated by the ChromaLink Biotin One-shot antibody labeling kit,
product of Solulink Inc. (San Diego, CA, USA). The biotinylation process was monitored by
measuring changes in the optical absorption of the reaction mixture. The calculated biotin
molar substitution ratio is 8.35, indicating efficient binding of 6C3. A total of 86 μg of antibody
was recovered after the reaction.
Transcription reaction
The transcription reaction was initiated by incubating 200 μg of NC in 200 μl of transcription
reaction mixture [pH 8.8; 70 mM of bicine; 1 mM of Mg Acetate; 3 mM of MnCl2; 125 mM of
NH4Cl; 20 mM of DTT; 0.25 U/L of RNasin; approximately 100 μg of macaloid (bentonite
clay); and 4 mM of each of the rNTPs] for 1 h at 20°C [28]. As a control, the same amount of
NC was utilized in the transcription reaction mixture but without the addition of rNTPs. For
each sample, 45 μL was used for RNA transcript extraction. Samples were electrophoresed in
1% agarose gels and stained with ethidium bromide. The cryo-TEM visualization of transcrib-
ing NCs used 5 μl each of the control and reaction samples. Electron micrographs were ac-
quired with a JEOL 2100 electron microscope (JEOL Inc. Peabody, MA, USA) operating at
200 keV and a Gatan Orius 2048 × 2048 pixel CCD (Gatan Inc., Pleasanton, CA, USA).
Sandwich ELISA of transcribing NCs
Two Mabs with different epitope recognition, 1C10 and 6C3, were chosen for the sandwich-
based ELISA of the NC. The capture antibody was 1C10 and the detecting antibody was bioti-
nylated 6C3. ELISA plates were coated with 5 μg/ml of 1C10 (the Mabs were dissolved in 0.2 M
of carbonate-bicarbonate buffer at pH 9.4). The plates were then blocked with 1% BSA in PBS.
The transcription reaction mixture (50 μl) was applied to the first well and subsequent 2-fold
dilutions with PBS were applied to the remaining wells. Two control samples consisted of: (1)
NCs in 100 mM Tris buffer and (2) NCs in transcription buffer but lacking rNTPs were em-
ployed for comparison. Following the addition of biotinylated 6C3, plates were incubated with
a 1:1000 dilution of streptavidin conjugated with alkaline phosphatase. Substrate solution was
added and plates were read at 405 nm using a Titertek Multiscan ELISA reader (TiterTek, Bert-
hold, Pforzheim, Germany).
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Results and Discussion
Isolation of ϕ6 P7, inoculation of mice, and genetic classification of the
monoclonal antibodies
The SDS-PAGE gel taken at different steps of the P7 purification procedure is shown in Fig. 1
and demonstrates that recombinant his-tagged protein P7 is produced to a high percentage in
E. coli in a soluble state. The protein was bound to Ni-NTA beads efficiently eluted with
250 mM of imidazole. Purity was estimated from the coomassie-stained SDS-PAGE and the P7
protein was observed to migrate at a molecular mass of approximately 17 kDa. 50 μg of native
form P7 in CFA was used to intraperitoneally inoculate 6-week-old female, BALB/c mice. Two
booster inoculations which included P7 emulsified inIFA were administered at days 21 and 51.
The Mabs were selected, purified, and their reactivity with P7 investigated. Fig. 2 shows a
12% SDS-PAGE gel of the Mabs revealing the heavy and light chains of the purified IgG mono-
clonals. The heavy chain molecular weights are 52 KDa for 6C3; and 49 KDa for 2D11, 1B6,
1F11 and 1C10. The light chain molecular weights are 28 KDa for 6C3; and 23 KDa for 2D11,
1B6, 1F11 and 1C10. All five antibodies utilize the IgG1 subclass and the κ light chain as deter-
mined by ELISA. The variable region cDNA sequences derived from mRNA of the hybridomas
were analyzed by IgBLAST and classification comparisons were made to the mouse database
[29]. Sequence analysis reveals that Mabs 1C10, 1B6, 2D11, and 1F11 all utilize a Vκ derived
from the same germline gene, Vκ4-5901 and a VH gene derived from the VH5 family, either
the VH5-9-301 or VH5-1702 genes (Table 1). A germline analysis search demonstrates that
2D11 is similar to 1B6, and 1C10 is similar to 1F11 and therefore could be derived from the
same myeloma fusion. In Table 1, the germline gene with the highest alignment is recorded.
Fig 1. SDS-PAGE gel demonstrating effectiveness of P7 purification procedure. Lanes are: Marker
(wide range protein ladder p7708); Control—undisrupted cells after IPTG induction; SN—supernatant after
the pelleting of lysed cell’s debris; Pellet—resuspended cell debris pellet; Flow-Through—proteins unbound
to Ni-NTA beads; 1st and 2nd Wash—proteins eluted from the Ni-NTA agarose column after 1st and 2nd rinses
with washing buffer; Eluate—P7 protein eluted from the column.
doi:10.1371/journal.pone.0122160.g001
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The restricted utilization of Vκ genes and VH genes among 1F11, 1B6, 1C10, and 2D11 suggests
that P7 elicits a limited antibody repertoire. We acknowledge that the mutational differences
between the similar Mabs could be PCR artifacts, however, the lower binding affinities of 1B6
compared to 2D11, and 1F11 compared to 1C10, suggests that they are independent clones.
Mab 6C3 differs significantly from the other Mabs and utilizes the VK8–2101 gene and the
V2-9-101 heavy chain gene. Query of the IMGT gene database [30] for Mus musculus indicat-
ed that a significant number of antibodies utilizing the VK8-2101 light chain variable region
gene and the V2-9-101 gene have specificity for dsDNA. Antibody 6C3 most likely binds a
strictly conformational epitope on P7 (see below) that could structurally mimic double strand-
ed nucleic acid polymers thereby eliciting cross-reactivity with dsDNA or dsRNA. Antibody to
another viral protein, EBNA-1 has previously been shown to cross-react with dsDNA [31,32].
However 6C3 displayed no cross-reactivity to either dsRNA or dsDNA in nucleic- acid based
ELISA tests. It should be noted as well that a search of the database for antibodies utilizing the
Vκ4-5901, or the VH5-9-201 or VH5-1702 genes showed virtually no anti-DNA specificity.
P7 binding characteristics of the monoclonal antibodies
Fig. 3 shows the calibration curve for the binding affinity of each Mab to the native P7 antigen.
The ELISA plates were coated with P7 native protein with concentrations ranging from
5 ng/ml to 1000 ng/ml (0.25 ng to 50 ng of P7 per ELISA well). The coating was performed at
4°C overnight to limit the rate of protein denaturation. We first performed preliminary assays
to determine the optimal Mab concentration that produced a maximum optical response with
Fig 2. SDS-PAGE gel of purified Mabs.MWof the heavy chains are 52 kDa for 6C3; and 49 kDa for 2D11,
1F11 and 1C10. MW of the light chains are 28 kDa for 6C3; and 23 kDa for 2D11, 1F11 and 1C10.
doi:10.1371/journal.pone.0122160.g002
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the lowest background signal and found that concentration to be 1 μg/ml. Two distinct groups
of antibodies, based on antigen affinity, were isolated which had the highest dynamic range
for optical absorption. The groups were classified based upon the P7 antigen ELISA response
with the following range of linear increase: 1) 20 ng/ml to 100 ng/ml for 6C3 antibody; and 2)
10 ng/ml to 50 ng/ml for the other four Mabs (Fig. 3).
In order to categorize the epitopes as potentially linear or conformational for anti-P7
antibody, equal amounts of either native or denatured proteins were applied to ELISA plate
wells. Each experimental group was performed in triplicate. Fig. 4 shows the optical density at
405 nm for an ELISA performed using both native and denatured P7 antigens. No significant
difference in the reactivity of 1C10, 2D11, and 1F11 Mabs to native and denatured forms of P7
were observed. This suggests that these Mabs recognize linear epitopes of the P7 antigen. Sig-
nificant differences in the reactivity of 6C3 and 1B6 between native and denatured P7 indicates
that they likely recognizes a conformational epitope. Additional proof of this hypothesis is
noted by the result of the Western Blot analysis in that the P7 band is visualized after 1C10,
2D11 and 1F11 labeling, but weak with 1B6, and almost no affinity with 6C3 labeling (Fig. 4B).
Competition assays
A competitive ELISA analysis was performed to determine if the Mabs competed for the same
epitopes on P7. In the assays, 1.25 ng of native P7 was placed into each of four sets of wells of
an ELISA plate. One μg/ml of each Mab was applied to each set of ELISA plate wells. Increasing
concentrations of the other three competitor Mabs, were applied separately to each of the
ELISA sets. Since all the Mabs are of the γ1 isotype, we cannot directly measure inhibition.
Therefore if the saturating and the competitor antibodies are binding the same epitope, we
Fig 3. Affinity calibration curve for the P7 Mabs. Mabs concentrations were 1 μg/ml. The background
absorption for each Mab was determined from the optical density of ELISA plate wells lacking the P7 antigen,
and the background optical density was subtracted from the absorption data.
doi:10.1371/journal.pone.0122160.g003
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would expect no change in net γ1 antibody binding to P7 even at very high concentrations of
the competitor. However, if the saturating and the competitor antibodies are not competing for
the same site and are binding different epitopes on P7, then one would expect to see an increase
in γ1 antibody binding to P7 with increasing concentration of the competitor. As a control, in-
creasing concentrations of individual Mabs were applied to sets of plates. The control absorp-
tion data is presented in Fig. 5A. Optical absorption for wells with saturating Mabs are shown
Fig 4. Reactivity of Mabs. A) Comparison of the reactivity of the Mabs 1C10, 6C3, 2D11 and 1F11 to the
native and denatured forms of P7. P7 was coated at a concentration of 31.2 ng/ml (1.6 ng per ELISA plate
well). Optical density is measured at 405 nm. B) Western Blot of P7 protein.
doi:10.1371/journal.pone.0122160.g004
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in panels 5B through 5E (B: 6C3; C: 1C10; D: 2D11; E: 1F11). It is evident from Fig. 5B that the
reactivity of 6C3 increases regardless of the competitor antibody, indicating a lack of
Fig 5. Competition betweenMabs determined by ELISA. A) Single Mab (no competition); B) 6C3; C)
1C10; D) 2D11; and E) 1F11; in competition with the other three Mabs at concentrations of 1000 ng/ml.
Optical Density is measured at 405 nm.
doi:10.1371/journal.pone.0122160.g005
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competition between 6C3 and the other three Mabs. For each of the other three sets of wells
containing saturating Mabs concentrations, absorption only increases for increased 6C3 con-
centration—consistent with the results presented in panel B. For none of the other combina-
tions of Mabs does the absorption increase indicating that 1C10, 2D11 and 1F11 are all
competing for the same sites on P7. Interestingly, the 6C3 reactivity is not additive with the
other three antibodies as evidenced by the fact that optical densities of the mixtures of 6C3
with the other three Mabs is greater than the sum of optical densities of the individual reactions
(Fig. 5A). This suggests there could be a synergistic cooperation between 6C3 and each of the
other Mabs. It is conceivable that the antigen is structurally altered after binding with the ini-
tially added antibody better revealing the second epitope.
Transcribing nucleocapsids can be captured in ELISA
The standard in vitro NC transcription reaction described by EmoriIba and Okada [28] was es-
tablished to resemble the early-stage pattern of in vivo viral RNA synthesis in which greater
proportion of l transcript is synthesized. The standard reaction is defined by its strict require-
ment for cations, pH, and l synthesis was found to be exceptionally sensitive to Mn2+ concen-
tration. In addition the early stage of transcription could be associated with a limited or
partially assembled P8 matrix. We suggest that the partial disassembly of the NC could occur
in the standard reaction and if so the P7 would be in an exposed position. The monoclonal an-
tibodies are ideal reagents for the capture of NC particles primed for transcription assuming
the P7 is no longer shielded in the inner 3 fold axis of the procapsid [21] but has translocated
to an open NC position post-RNA packaging.
In order to determine if the Mabs were able to bind to the P7 protein in situ, we performed a
sandwich—based ELISA. We chose as a capture antibodies 1C10, 2D11, and 1F11. Antibody
6C3—that recognizes a P7 epitope distinct from 1C10, 2D11, and 1F11- was biotinylated to
serve as the detector. The ELISA plate wells were coated with capture antibody at a 5 ug/ml
concentration. 50 ul of the NC early phase transcription reaction was applied to the first well
and serial 2-fold dilutions in PBS of the reaction mixture were applied to the remaining wells
in the ELISA plate row. Two control samples consisted of (1) NC in 100 mM Tris buffer (pH
7.5) and (2) NC in early phase transcription buffer but lacking rNTPs. Following the addition
of the biotinylated 6C3 the plates were incubated with a 1:1000 streptavidin conjugated alkaline
phosphatase. The substrate solution was added and the degree of NC capture was determined
at 405 nm with a Titertek Multiscan ELISA reader. Fig. 6 shows the binding of the Mabs to ϕ6
NC samples after the transcription reaction and that only NCs that were placed into the early
phase reaction were captured in the ELISA wells and detected with antibody 6C3. The capture
was achieved in early phase buffer in the presence of absence of rNTPs indicating that the NC
partial disassembly was nucleotide independent.
We confirmed the partial disassembly of the NC using cryo-EM imaging of early phase tran-
scription reaction mixtures. Cryo-EM projection images of the control (Fig. 7A) shows a large
number of intact NCs which appear as 58 nm diameter particles with a high electron density
due to the large contribution from the P8 matrix. A corresponding cryo-EM projection image
of transcribing NCs (Fig. 7B) reveals that approximately 1/3 of the particles are in an interme-
diate state in which the P8 matrix is disassembled. NC transcription results in a virion appear-
ing as an expanded hexagonal-shaped PC structure with a reduced internal electron density.
Several of these transcribing particles are indicated by black arrows in Fig. 7B.
We note that the transcribing NC particles and controls (that are primed for transcription
in the standard reaction conditions but lacking rNTPs) showed the increasing amount of
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available P7 in the ELISA reaction. The NCs maintained and tested in 100 mM Tris-HCl buffer
(pH 8.0) did not have any evident immunolabeling.
The results of both the projection EM and sandwich assay analysis indicate that the P8 ma-
trix is destabilized and likely completely or partially disassembled under in vitro transcribing
conditions- either with or without 4mM rNTPs. The precise position of the transcribing viral
RNA within the partially disassembled NC is not evident and its transit path through the portal
Fig 6. Sandwich ELISA showing that NC reveals P7 in transcription buffer with or without rNTP.
Absorption is measured at 405 nm.
doi:10.1371/journal.pone.0122160.g006
Fig 7. Cryo TEM images of transcribing ϕ6 NCs. A) Control sample (no rNTP in transcription reaction mixture); B) NC in 4 mM of rNTP in transcription
reaction mixture. Arrows in (B) indicate some of the transcribing NCs (hexagonal configuration with a lower electron density).
doi:10.1371/journal.pone.0122160.g007
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remains to be determined. Notably the addition of Mabs 6C3 or 1C10 to NC transcribing reac-
tions had no effect on synthesis of viral RNA transcripts.
We conclude the following from the assays: (1) monoclonal antibodies can be elicited from
mice that recognize unique linear and conformational epitopes of protein P7; (2) Three of the
four Mabs derived from distinct B-cell clones utilize identical Vκ and VH genes of the same
gene family demonstrating restricted gene utilization, while one, 6C3, which recognizes a con-
formational epitope, utilizes VH and Vκ genes frequently associated with anti-DNA antibodies;
and (3) monoclonal antibodies can be utilized alone or in combination as structural probes for
the disassembly or assembly of the ϕ6 nucleocapsid during transcription in the standard early-
stage reaction conditions. During NC transcription P7 is in an exposed position or in proximity
to the NC surface which is accessible to antibodies.
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